TRACON Pharmaceuticals Inc. (TCON) Declined -6.31% or -0.07 To Price $1.04 On Friday


TRACON Pharmaceuticals Inc. (TCON) declined -6.31% or -0.07 to $1.04. It is close to 267857 shares traded, which is 195.2% compare to the average total volume 137223. The market cap of TCON is $31.07 million. The year to date change is -74.59%. The 52 week price range is from $1.02 to $3.6. Price of TCON have changed -1.77% during last week. It have changed -18.98% over last month, -49.55% over last 3 months, -57.31% over last 6 months and -62.69% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for TCON is 1.46. It is 40.38% above current price. The 200-day Moving Averages for TCON is 2.24. It is 115.38% above current price. The 52-week High is 3.6. It is 246.15% from the current price. The 52-week Low is 1.02. It is -1.92% from current price.

There are some statistics of TCON. It is has market cap $31.07 million. The share outstanding is 29.87 million. The average volume is 137223. The percent of top 15 Institution holding is 62.90%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of TCON is -134.05%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of TCON is -78.64%.


Tags:

Share this post